139 related articles for article (PubMed ID: 36542644)
1. Long-term benefits for lower socioeconomic groups by improving bowel screening participation in South Australia: A modelling study.
Lal A; Gao L; Tan E; McCaffrey N; Roder D; Buckley E
PLoS One; 2022; 17(12):e0279177. PubMed ID: 36542644
[TBL] [Abstract][Full Text] [Related]
2. Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study.
Lew JB; St John DJB; Xu XM; Greuter MJE; Caruana M; Cenin DR; He E; Saville M; Grogan P; Coupé VMH; Canfell K
Lancet Public Health; 2017 Jul; 2(7):e331-e340. PubMed ID: 29253458
[TBL] [Abstract][Full Text] [Related]
3. Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment.
Worthington J; Lew JB; Feletto E; Holden CA; Worthley DL; Miller C; Canfell K
PLoS One; 2020; 15(2):e0227899. PubMed ID: 32012174
[TBL] [Abstract][Full Text] [Related]
4. Modelling cost-effective strategies for minimising socioeconomic inequalities in colorectal cancer screening outcomes in England.
Thomas C; Mandrik O; Whyte S
Prev Med; 2022 Sep; 162():107131. PubMed ID: 35803353
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
Sharma T
Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
[TBL] [Abstract][Full Text] [Related]
6. Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study.
Cross AJ; Robbins EC; Pack K; Stenson I; Kirby PL; Patel B; Rutter MD; Veitch AM; Saunders BP; Little M; Gray A; Duffy SW; Wooldrage K
Health Technol Assess; 2022 May; 26(26):1-156. PubMed ID: 35635015
[TBL] [Abstract][Full Text] [Related]
7. Long-term risk of colorectal cancer after screen-detected adenoma: Experiences from a Danish gFOBT-positive screening cohort.
Bjerrum A; Lindebjerg J; Andersen O; Fischer A; Lynge E
Int J Cancer; 2020 Aug; 147(4):940-947. PubMed ID: 31894860
[TBL] [Abstract][Full Text] [Related]
8. Equity of colorectal cancer screening: which groups have inequitable participation and what can we do about it?
Ward PR; Javanparast S; Wilson C
Aust J Prim Health; 2011; 17(4):334-46. PubMed ID: 22112702
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer screening in rural and remote areas: analysis of the National Bowel Cancer Screening Program data for South Australia.
Martini A; Javanparast S; Ward PR; Baratiny G; Gill T; Cole S; Tsourtos G; Aylward P; Jiwa M; Misan G; Wilson C; Young GP
Rural Remote Health; 2011; 11(2):1648. PubMed ID: 21585228
[TBL] [Abstract][Full Text] [Related]
10. Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION): A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population.
Kim B; Lairson DR; Chung TH; Kim J; Shokar NK
Value Health; 2017 Jun; 20(6):809-818. PubMed ID: 28577699
[TBL] [Abstract][Full Text] [Related]
11. Family history-based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios.
Dillon M; Flander L; Buchanan DD; Macrae FA; Emery JD; Winship IM; Boussioutas A; Giles GG; Hopper JL; Jenkins MA; Ait Ouakrim D
PLoS Med; 2018 Aug; 15(8):e1002630. PubMed ID: 30114221
[TBL] [Abstract][Full Text] [Related]
12. The projected health and economic impact of increased colorectal cancer screening participation among Canadians by income quintile.
Adegbulugbe AA; Farah E; Ruan Y; Yong JHE; Cheung WY; Brenner DR
Can J Public Health; 2024 Mar; ():. PubMed ID: 38502494
[TBL] [Abstract][Full Text] [Related]
13. Detection of cancers and advanced adenomas in asymptomatic participants in colorectal cancer screening: a cross-sectional study.
Schult AL; Botteri E; Hoff G; Randel KR; Dalén E; Eskeland SL; Holme Ø; de Lange T
BMJ Open; 2021 Jul; 11(7):e048183. PubMed ID: 34210732
[TBL] [Abstract][Full Text] [Related]
14. Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing.
van der Meulen MP; Toes-Zoutendijk E; Spaander MCW; Dekker E; Bonfrer JMG; van Vuuren AJ; Kuipers EJ; van Kemenade FJ; van Velthuysen MF; Thomeer MGJ; van Veldhuizen H; de Koning HJ; Lansdorp-Vogelaar I; van Leerdam ME
PLoS One; 2022; 17(2):e0264067. PubMed ID: 35176116
[TBL] [Abstract][Full Text] [Related]
15. The potential for tailored screening to reduce bowel cancer mortality for Aboriginal and Torres Strait Islander peoples in Australia: Modelling study.
Lew JB; Feletto E; Worthington J; Roder D; Canuto K; Miller C; D'Onise K; Canfell K
J Cancer Policy; 2022 Jun; 32():100325. PubMed ID: 35560263
[TBL] [Abstract][Full Text] [Related]
16. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
[TBL] [Abstract][Full Text] [Related]
17. Socioeconomic position and participation in colorectal cancer screening.
Frederiksen BL; Jørgensen T; Brasso K; Holten I; Osler M
Br J Cancer; 2010 Nov; 103(10):1496-501. PubMed ID: 20959827
[TBL] [Abstract][Full Text] [Related]
18. Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives.
Hathway JM; Miller-Wilson LA; Jensen IS; Ozbay B; Regan C; Jena AB; Weinstein MC; Parks PD
J Med Econ; 2020 Jun; 23(6):581-592. PubMed ID: 32063100
[No Abstract] [Full Text] [Related]
19. The relative effectiveness of fecal immunochemical test-based colorectal cancer screening to detect adenomas and cancer in different demographic and socioeconomic groups. A nationwide cohort study.
Larsen MB; Søborg B; Njor SH; Jensen TM; Ingeholm P; Andersen B
Eur J Cancer Prev; 2022 Nov; 31(6):489-496. PubMed ID: 35485399
[TBL] [Abstract][Full Text] [Related]
20. Knowledge of, attitudes toward, and barriers to participation of colorectal cancer screening tests in the Asia-Pacific region: a multicenter study.
Koo JH; Leong RW; Ching J; Yeoh KG; Wu DC; Murdani A; Cai Q; Chiu HM; Chong VH; Rerknimitr R; Goh KL; Hilmi I; Byeon JS; Niaz SK; Siddique A; Wu KC; Matsuda T; Makharia G; Sollano J; Lee SK; Sung JJ;
Gastrointest Endosc; 2012 Jul; 76(1):126-35. PubMed ID: 22726471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
